TB-500 operates systemically by regulating actin for cell migration and wound healing
PubMed 22962027 TB-4 Phase 1 human safety first-in-human randomized, double-blind, single- and multiple-dose Phase 1 of recombinant human thymosin 4 in healthy volunteers, no serious adverse events: PubMed 34346165
After the two-month break, patients who continue into a second cycle return directly to the month-three maintenance dose rather than restarting the ramp from month one
Clin Infect Dis (1999) 29:4523
This necessitates frequent dosing for sustained effects but provides rapid clearance that minimizes accumulation risks
We serve patients from Omaha NE, Boys Town NE, Diamond Head NE, Elkhorn NE, Bennington NE, Valley NE, and surrounding areas